According to a new report Europe Molecular Diagnostics Market, published by KBV Research, the Europe Molecular Diagnostics Market is expected to register a CAGR of 7.8% during the forecast period (2016 - 2022). The Reagents & Kits market dominated the Europe Molecular Diagnostics Market by Product & Services in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 5.9 % during the forecast period. The Instruments market is expected to witness a CAGR of 9.9% during (2016 - 2022). Additionally, The Software & Services market is expected to witness a CAGR of 11.1% during (2016 - 2022).
The Germany market dominated the Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 4.8 % during the forecast period. The UK market is expected to witness a CAGR of 4.1% during (2016 - 2022). Additionally, The France market is expected to witness a CAGR of 6.7% during (2016 - 2022). The Infectious Diseases market dominated the Germany Molecular Diagnostics Market by Application in 2015, and would continue to be a dominant market till 2022.
The Other Applications market is expected to witness a CAGR of 10.2% during (2016 - 2022). The Oncology market is expected to witness a CAGR of 7.1% during (2016 - 2022). The Chlamydia Trachomatis & Neisseria Gonorrhea market dominated the Germany Infectious Diseases Molecular Diagnostics Market by Type in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 4.1 % during the forecast period. The Human Papillomavirus market is expected to witness a CAGR of 3.7% during (2016 - 2022).
Additionally, The Tuberculosis market is expected to witness a CAGR of 4.9% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key influencing factors of the EuropeMolecular Diagnostics have been discussed in the report along with the elaborated company profiles of Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
Full report: https://www.kbvresearch.com/europe-molecular-diagnostics-market/
Research Scope
Global Molecular Diagnostics Market
North America Molecular Diagnostics Market
Unique Offerings 
